PING AN BIOMEDICAL CO-A (PASW:NASDAQ)
$5.07 -0.29 (-5.4104%)
Analysed PING AN BIOMEDICAL CO-A (PASW:NASDAQ) News Sources
Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter
28-11-2025
yahoo.com
Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation
09-01-2026
yahoo.com
Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry
09-01-2026
yahoo.com
All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital
19-03-2026
yahoo.com
Ping An Biomedical Announces Planned Acquisition of Three Tumor Cell-Related Medical Technology Patents to Build a Core Oncology and Biotech Intellectual Property Portfolio
22-10-2026
yahoo.com
Ping An Biomedical and Yuan Sheng Mei Yan Sign Strategic Cooperation Agreement, Targeting RMB 500 Million in Sales Over Three Years
22-07-2026
yahoo.com
Ping An Biomedical Announces 1-for-40 Reverse Stock Split
21-10-2026
yahoo.com
What is the current price of PING AN BIOMEDICAL CO-A (PASW:NASDAQ)?
The current price of PING AN BIOMEDICAL CO-A (PASW:NASDAQ) is $5.07.
PING AN BIOMEDICAL CO-A (PASW:NASDAQ) absolute price change since previous trading day?
The absolute price change of PING AN BIOMEDICAL CO-A (PASW:NASDAQ) since the previous trading day is $-0.29.
PING AN BIOMEDICAL CO-A (PASW:NASDAQ) percentage price change since previous trading day?
The percentage price change of PING AN BIOMEDICAL CO-A (PASW:NASDAQ) since the previous trading day is -5.4104%.
What is the most recent average sentiment score for PING AN BIOMEDICAL CO-A (PASW:NASDAQ)?
The most recent average sentiment score for PING AN BIOMEDICAL CO-A (PASW:NASDAQ) is 60 out of 100.
What is the most recent average sentiment for PING AN BIOMEDICAL CO-A (PASW:NASDAQ)?
The most recent sentiment for PING AN BIOMEDICAL CO-A (PASW:NASDAQ) is .
SEC-8K** Filing Available For PING AN BIOMEDICAL CO-A (PASW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.